Developing a gene therapy for fetal disease: an interview with Anna David

Written by RegMedNet

Anna David (University College London, UK) discusses her research into the development of new treatments for fetal growth restriction using maternal gene therapy. Filmed at this year’s American Association of Pharmaceutical Scientists’ (AAPS) workshop on Opportunities and Challenges in Translating Cell and Gene Therapy Products (4—5 September; London, UK), we spoke to Anna David (University College London, UK) to look behind her lecture. In the interview, she discusses the challenges of administering a fetal gene therapy, her experiences working with the UK regulators and more. Find out more in these top picks from the Editor: CRISPR scientist claims to have...

To view this content, please register now for access

It's completely free